REG - Hikma Pharmaceutical - Director/PDMR Shareholding
RNS Number : 8614IHikma Pharmaceuticals Plc13 August 2019Notification and public disclosure of transactions by persons discharging managerial responsibilities
Khalid Nabilsi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Khalid Nabilsi
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Disposal of 45,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)
Price(s) and volume(s)
Price(s): £19.48
Volume(s): 10,000
Price(s): £19.50
Volume(s): 5,000
Price(s): £19.79
Volume(s): 25,000
Price(s): £19.75
Volume(s): 5,000
d)
Aggregated information
Aggregated volume: 45,000
Price: £19.68
Total: £885,600
e)
Date of the transaction
9 and 12 August 2019
f)
Place of the transaction
London Stock Exchange (XLON)
Bassam Kanaan
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bassam Kanaan
2
Reason for the notification
a)
Position/status
EVP, Corporate Development and M&A
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Disposal of 84,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)
Price(s) and volume(s)
Price(s): £19.47
Volume(s): 15,000
Price(s): £19.72
Volume(s): 50,000
Price(s): £19.79
Volume(s): 5,000
Price(s): £19.72
Volume(s): 4,500
Price(s): £19.75
Volume(s): 5,000
Price(s): £19.70
Volume(s): 5,000
d)
Aggregated information
Aggregated volume: 84,500
Price: £19.68
Total: £1,662,990
e)
Date of the transaction
9 and 12 August 2019
f)
Place of the transaction
London Stock Exchange (XLON)
Peter Speirs, Company Secretary, Responsible for releasing this announcement
13 August 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHGCGDICBBBGCX
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement